New evidence explains how magic mushrooms could treat depression

magic mushrooms
Support us and go ad-free

There has been a resurgence in research on psychedelic drugs. And the results so far indicate a number of therapeutic benefits. Magic mushrooms, for example, appear promising in their ability to treat severe, treatment-resistant depression. A new study highlights how psilocybin (the main psychoactive compound in magic mushrooms) can lift people out of their depression.

How psilocybin changes the brain

Scientists found that patients with major depression receiving psilocybin-assisted therapy had increased amygdala responses to images of fearful faces. (The amygdala is the emotional centre of the brain.) Authors say this is associated with improvements in mental health.

Previous research indicates that psilocybin can offer depressed patients relief by ‘resetting’ their brain. Lead author Dr Robin Carhart-Harris (who was behind this newer study as well) said:

Based on what we know from various brain imaging studies with psychedelics, as well as taking heed of what people say about their experiences, it may be that psychedelics do indeed ‘reset’ the brain networks associated with depression, effectively enabling them to be lifted from the depressed state.

Patients experienced these benefits after just one day, and continued to experience them five weeks later.

Magic mushrooms compared to antidepressants

It also seems that psilocybin relieves the symptoms of depression in a way quite different from SSRIs (selective serotonin reuptake inhibitors) – commonly prescribed antidepressants, which include fluoxetine (Prozac). The study states:

Psilocybin with psychological support was associated with increased amygdala responses to emotional stimuli, an opposite effect to previous findings with SSRIs. This suggests fundamental differences in these treatments’ therapeutic actions, with SSRIs mitigating negative emotions and psilocybin allowing patients to confront and work through them. Based on the present results, we propose that psilocybin with psychological support is a treatment approach that potentially revives emotional responsiveness in depression, enabling patients to reconnect with their emotions.

Read on...

Support us and go ad-free

SSRIs have sometimes been linked to emotional blunting. Leor Roseman, a PhD student who is part of the Psychedelic Research Group at Imperial College London (headed by Carhart-Harris), also says:

It is important to emphasize that psilocybin-assisted therapy is a model in which the patient is undergoing a deep psychological process in one or few psychedelic sessions, in which he might have an intense cathartic experience, or peak experience.


As promising as these results are, there are still some limitations with the study. Roseman highlights:

The major caveats are a lack of control group, a lack of SSRI group, and that the time point of investigation is only one day after the psilocybin session and not more than that. All of these caveats will be addressed in our next trial.

Increasingly, it is being shown in controlled, clinical trials that psychedelics can improve people’s mental health when all other treatment options have failed. As Roseman points out, we need further research to show how compounds like psilocybin can achieve such impressive results. But as the evidence builds, it is becoming clear why psychedelic-assisted therapy should be taken seriously.

Get Involved!

– Read more articles from The Canary on psychedelics.

Join us, so we can keep bringing you the news that matters.

Featured image via Wikimedia

Support us and go ad-free

We need your help to keep speaking the truth

Every story that you have come to us with; each injustice you have asked us to investigate; every campaign we have fought; each of your unheard voices we amplified; we do this for you. We are making a difference on your behalf.

Our fight is your fight. You’ve supported our collective struggle every time you gave us a like; and every time you shared our work across social media. Now we need you to support us with a monthly donation.

We have published nearly 2,000 articles and over 50 films in 2021. And we want to do this and more in 2022 but we don’t have enough money to go on at this pace. So, if you value our work and want us to continue then please join us and be part of The Canary family.

In return, you get:

* Advert free reading experience
* Quarterly group video call with the Editor-in-Chief
* Behind the scenes monthly e-newsletter
* 20% discount in our shop

Almost all of our spending goes to the people who make The Canary’s content. So your contribution directly supports our writers and enables us to continue to do what we do: speaking truth, powered by you. We have weathered many attempts to shut us down and silence our vital opposition to an increasingly fascist government and right-wing mainstream media.

With your help we can continue:

* Holding political and state power to account
* Advocating for the people the system marginalises
* Being a media outlet that upholds the highest standards
* Campaigning on the issues others won’t
* Putting your lives central to everything we do

We are a drop of truth in an ocean of deceit. But we can’t do this without your support. So please, can you help us continue the fight?

The Canary Support us

Comments are closed